Smoking prevalence in individuals with opioid use disorder (OUD) is over 80%. Research suggests that opioid use significantly increases smoking, which could account for the strikingly low smoking-cessation rates observed in both methadone- and buprenorphine-maintained patients, even with the use of first-line smoking-cessation interventions. If…[Read more]

Results Fifty-nine AYAs (mean 19 years) participated in the study. Acceptability and attrition were 80% and 12%, respectively. Between T1 and T2, 6MWD and global QoL improved (p  less then  0.001), and fatigue decreased (p = 0.003). Total PA improved and sitting time decreased (p  less then  0.001) overall (T1-T3). selleck kinase inhibitor[Read more]